Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Compumedics Limited ( (AU:CMP) ) has shared an announcement.
Compumedics Limited has reaffirmed its commitment to high standards of corporate governance, emphasizing the importance of a strong relationship between the Board and senior management for the Group’s long-term success. The Board’s responsibilities include strategic guidance, financial oversight, and ensuring effective management processes, with a focus on enhancing shareholder and stakeholder interests.
The most recent analyst rating on (AU:CMP) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Compumedics Limited stock, see the AU:CMP Stock Forecast page.
More about Compumedics Limited
Compumedics Limited operates in the medical technology industry, focusing on the development and commercialization of diagnostic and monitoring equipment. The company primarily offers products and services related to sleep, brain, and ultrasonic blood flow monitoring, catering to healthcare providers and research institutions.
Average Trading Volume: 112,166
Technical Sentiment Signal: Sell
Current Market Cap: A$54.78M
Learn more about CMP stock on TipRanks’ Stock Analysis page.